SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

CRISPR labs are — to put it succinctly — very, very nice. Everything that can be made of glass is made of glass. There are seemingly gratuitous wood accents, and just about everything is clean and ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...

CRISPR is a gene-editing tool that acts like “molecular scissors,” but using it on cancer is complex. The technology’s biggest impact so far is in research labs, helping scientists understand how ...

AI drug developer partners with big pharma and Amazon, expects Korea collaborations AION Labs builds start‑ups with big ...

He Jiankui, PhD, a Chinese scientist who sparked controversy in 2018 after claiming to have genetically modified two human embryos, is on a new scientific endeavor: trying to develop a therapy for ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...

This article was written for our sponsor, Innovation Road Trip. Eradication of certain diseases, increasing crop sizes, reducing pest populations — the current and future applications of CRISPR have ...